About SAiGENCI

Our ambition is to drive groundbreaking cancer research in South Australia’s biomedical precinct through enabling South Australia in the growing Australian network of cancer institutes, and national and international cancer research partnerships.

SAiGENCI is founded on a team-science strategy to coordinate the diverse expertise required to both prevent cancer and increase the efficacy of treatments and decrease the burden of cancer care. The SAiGENCI team is comprised of internationally recognised laboratory clinical researchers. The Institute is also collaborating with like-minded centres of excellence across the globe and is part of the global effort to deliver world-class and life-changing treatments and outcomes for cancer patients.

SAiGENCI governance

SAiGENCI is guided by strong, collaborative governance that ensures its research delivers meaningful impact. The Institute is led by a team of research program leads and overseen by an independent Advisory Board, comprising nominees from government, academics and local health networks.

The Board sets and monitors the strategy and policy direction for the Institute, reviews and approves its activities and expenditure, and supports the University in meeting its obligations under the Commonwealth Funding Deed. It is advisory and resides within the overarching framework within the College of Health at Adelaide University.

This combination of leadership and advisory expertise allows the Institute to respond effectively to complex projects, strengthens connections, encourages collaboration, and amplifies the impact of the Institute’s work on communities across Australia.